This article was originally published in The Rose Sheet
Selsun Blue domestic sales rose 38% in first quarter (ended Feb. 28) versus the same period last year, when the brand was marketed by former owner Abbott Labs, Chattanooga, Tenn. firm reports during March 21 analysts call. Chattem, which bought Selsun Blue in March of 2002, renewed ad support for the brand in June (1"The Rose Sheet" April 15, 2002, p. 9). Double-digit growth for Gold Bond and pHisoderm in Q1 was achieved on the launch of new products. The performance of all three brands helped spur a 20.7% increase in Chattem's net revenues to $58.4 mil. in Q1, while net income reached $4.6 mil., compared to a $6.5 mil. loss last year. Chattem also announced it acquired certain international trademarks for the pHisoderm brand from GlaxoSmithKline in an effort to expand its pHisoderm business globally...
You may also be interested in...
Chattem's advertising strategy focuses on acquiring media time "as a guerilla buyer as opposed to a big buyer," CEO Zan Guerry maintained at a Banc of America Securities consumer conference in New York April 8-10
STADA Strengthens Specialty Partnership Role Via US Filing
Antoine Marchal, Franchise Head PCR Core Labs - BA Molecular Diagnostics at Qiagen outlines how NeuModx will strengthen its position in the infectious disease space.